Healthcare AI gains operational adoption but faces an evidence gap

Basalt Health raised a $20 million Series A led by NEA and reported an 86% chart-processing time reduction across health-system customers. Analysis showing only 34 registered trials and three patient-centered evaluations among 1,357 FDA-cleared AI devices, alongside Pennsylvania’s proposed rules, makes clinical validation and governance central to commercialization.